Shopping Cart
- Remove All
- Your shopping cart is currently empty
AB-161 is an orally active destabilizer of HBV RNA and an inhibitor of PAPD5/7, primarily targeting the liver. It treats hepatitis B virus (HBV) infection by reducing hepatitis B surface antigen (HBsAg) levels, exhibiting an EC50 value of 2.2 nM for HBsAg. AB-161 is applicable in HBV infection research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | AB-161 is an orally active destabilizer of HBV RNA and an inhibitor of PAPD5/7, primarily targeting the liver. It treats hepatitis B virus (HBV) infection by reducing hepatitis B surface antigen (HBsAg) levels, exhibiting an EC50 value of 2.2 nM for HBsAg. AB-161 is applicable in HBV infection research. |
Molecular Weight | 433.41 |
Formula | C21H21F2N3O5 |
Cas No. | 2848560-66-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.